TellMeGen packages health predisposition reports, pharmacogenetics, carrier screening, and ancestry from 50+ reference populations into a single kit starting around EUR99. That scope is broader than most mainstream competitors at a similar price.
The tradeoff is polish. If you want the smoothest interface and FDA-authorized health reports, 23andMe is the safer pick. Below, we break down what TellMeGen covers, where it falls short, and who should actually buy it.
Key Takeaways
- TellMeGen covers 400+ traits across health predispositions, carrier status, pharmacogenetics, personal traits, and ancestry.
- Starter (~EUR99) handles traits and basic ancestry. Advanced (~EUR199) adds the full health and pharmacogenetics suite.
- Ancestry spans 50+ reference populations with a more international focus than U.S.-centric competitors.
- The raw DNA upload option lets you access reports without buying a new kit.
- The platform is functional but not polished. 23andMe delivers a more refined experience with FDA-authorized health results.
Our Verdict
TellMeGen is a strong fit if you want broad health-plus-ancestry coverage in one purchase and do not mind a less refined interface. The Advanced kit’s 400+ trait reports — including pharmacogenetics and carrier screening — exceed what most chip-based kits offer under EUR200.
It is not the right first test for everyone. AncestryDNA’s 25+ million-user database and genealogy workflow are stronger if ancestry depth is your priority. 23andMe’s FDA-authorized health reports set a higher validation bar. TellMeGen fits best in the middle: buyers who want health breadth, international ancestry, and pharmacogenetics together without paying for multiple kits.
What You Get
TellMeGen sells two kit tiers. The gap between them matters more than the EUR100 price difference suggests.
Starter kit (~EUR99)
The Starter kit covers personal traits, wellness markers, and a basic ancestry breakdown across 50+ populations. You get trait-level reports comparable to lighter consumer kits. It works as an entry point if you want a general snapshot without the full health suite.
Advanced kit (~EUR199)
The Advanced kit adds health predisposition reports for conditions like type 2 diabetes and celiac disease, carrier screening for hereditary conditions, and pharmacogenetics covering how your body processes certain medications. Most consumer kits skip pharmacogenetics entirely. If the health side is your reason for testing, this tier justifies choosing TellMeGen over cheaper alternatives.
Raw DNA upload
TellMeGen accepts raw DNA uploads from 23andMe, AncestryDNA, and other major testing providers. That gives you a second entry path without buying another saliva kit. The upload option is useful if you already tested elsewhere and want access to TellMeGen’s health and pharmacogenetics library.
Ancestry coverage
Ancestry results draw from 50+ reference populations spanning Europe, Africa, Asia, the Americas, and Oceania. The international scope is broader than what U.S.-focused competitors typically provide. Ancestry is not TellMeGen’s strongest feature — the database is smaller than AncestryDNA’s — but the global population coverage is a genuine differentiator for buyers with non-European backgrounds.
Pros and Cons
Here is the practical tradeoff between TellMeGen and mainstream alternatives.
Pros
- Report breadth: 400+ traits across health predispositions, carrier status, pharmacogenetics, and ancestry in one purchase
- Pharmacogenetics included: Most consumer kits do not cover medication response at all
- International ancestry: 50+ reference populations with less U.S.-centric bias than competitors like 23andMe
- Upload flexibility: Raw DNA upload from major providers means you do not need to retest
Cons
- Interface lags behind competitors: The platform works, but navigation and report design trail 23andMe and AncestryDNA
- Ancestry depth is limited: AncestryDNA’s 25+ million-user database delivers better relative matching if genealogy is your goal
- Health reports are not FDA-authorized: Results are educational screening tools — follow up with a doctor for anything actionable
- Buying logic is less obvious: Mainstream kits have simpler one-product value propositions
Who It Is Best For
If you want one kit that covers health predispositions, carrier status, pharmacogenetics, and international ancestry together, TellMeGen is one of the few options under EUR200 that delivers all four. Start here if report breadth matters more to you than interface polish.
If you already tested with another provider and want a second opinion on health markers, the raw DNA upload path lets you access TellMeGen’s reports without paying for another saliva kit. The upload accepts data from 23andMe, AncestryDNA, and other major providers.
TellMeGen is not the right choice if your main goal is genealogy. AncestryDNA’s database and family-tree tools are built for that workflow. It is also not the strongest option if you want FDA-authorized health results — 23andMe is the better buy for validated consumer health reporting.
Pricing and Privacy
The Starter kit runs around EUR99 and the Advanced kit around EUR199, though pricing varies by region and promotions. Verify current prices on the TellMeGen storefront before purchasing. For a broader look at what DNA testing costs across the market, see our genetic testing cost guide.
TellMeGen is based in Valencia, Spain, which means GDPR protections apply to data handling. The privacy profile differs from U.S.-based competitors that center their platforms on relative matching and social discovery. Read the current privacy policy before testing if data retention matters to you.
On accuracy, consumer DNA health reports — from any provider — are screening tools, not diagnoses. If a TellMeGen result flags a health predisposition or carrier status that concerns you, talk to a genetic counselor before making medical decisions.
The Bottom Line
TellMeGen earns its place for buyers who want broad health-plus-ancestry coverage with an international focus. The Advanced kit’s combination of health predispositions, pharmacogenetics, carrier screening, and 50+ ancestry populations is hard to match under EUR200.
We recommend it for readers who prioritize report breadth over interface polish. For the cleaner mainstream alternative, read our 23andMe review. If ancestry is the priority, go to our ancestry DNA roundup. To compare pricing across the market, see our genetic testing cost guide.
